Menu Search
Equities

Surgery Partners Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1SP:MUN

Surgery Partners Inc

Actions
  • Price (EUR)11.50
  • Today's Change-0.50 / -4.17%
  • Shares traded--
  • 1 Year change-53.25%
  • Beta1.9798
Data delayed at least 15 minutes, as of Feb 06 2026 07:06 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 162 surgical facilities comprised of 143 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 250 locations in 30 states, including short-stay surgical hospitals.

  • Revenue in USD (TTM)3.29bn
  • Net income in USD-171.40m
  • Incorporated2015
  • Employees15.00k
  • Location
    Surgery Partners Inc310 Seven Springs Way, Suite 500BRENTWOOD 37027United StatesUSA
  • Phone+1 (615) 234-5900
  • Fax+1 (615) 234-5998
  • Websitehttps://surgerypartners.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.